Push release MHRA approves GLP –one receptor agonist semaglutide to lower hazard of great coronary heart challenges in obese or overweight Grown ups Semaglutide is the primary weight-loss drug authorized in the UK as a preventative procedure for all those with set up heart problemsPediatric: Adverse reactions with Wegovy® in pediatric sufferers